Journal of the Korean Burn Society (대한화상학회지)

Korean Burn Society (대한화상학회)
권호 표지
DOI QR코드

DOI QR Code

Procalcitonin as a Predictor of Mortality in Burn Patients with Suspected Sepsis

패혈증이 의심되는 화상환자에서 Procalcitonin이 사망률 예측인자로서의 역할

  • Kim, In (Department of Surgery, Dongtan Sacred Heart Hospital, Hallym University) ;
  • Kym, Dohern (Department of Surgery, Burn Center, Hangang Sacred Heart Hospital, Hallym University)
  • 김인 (한림대학교 동탄성심병원 외과학교실) ;
  • 김도헌 (한림대학교 한강성심병원 화상센터 외과학교실)
  • Received : 2020.07.09
  • Accepted : 2020.09.21
  • Published : 2020.12.31
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to investigate the usefulness of Procalcitonin (PCT) as a predictor of mortality in patients with burn sepsis, which is closely related to mortality. Methods: A retrospective study was conducted on 912 PCT patients diagnosed with burn sepsis in patients who survived fluid resuscitation for at least 3 days, aged 18 years or older who were admitted to Burn Intensive Care Unit (BICU) of Hallym University Hangang Sacred Heart Hospital from January 2008 to December 2018. Results: Compared with the surviving group, TBSA (31%:65%), Inhalation (59.66%:74.23%) and ABSI (8 points:12 points) were statistically significantly higher in the death group. Looking at the changes in PCT levels in each survival and death group from Week 1 to Week 4, there was a statistically significant difference in PCT levels in the survival and death groups each week (P<0.001). Although there were statistical differences between the survival and death groups in each state (P<0.001), there was no difference in PCT values for each state in both groups (P=0.090). Conclusion: In burn patients suspected of sepsis, the use of PCT is useful for predicting survival and death. It is necessary to conduct research based on prospective study through systematization of measurement standards and data from multiple institutions to increase the utilization of PCT through research that complements the limitations.

Keywords

References

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:801-10. https://doi.org/10.1001/jama.2016.0287
  2. Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 2011;342:d3245. https://doi.org/10.1136/bmj.d3245
  3. Gul F, Arslantas MK, Cinel I, Kumar A. Changing definitions of sepsis. Turk J Anaesthesiol Reanim 2017;45:129-38. https://doi.org/10.5152/TJAR.2017.93753
  4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6. https://doi.org/10.1097/01.CCM.0000050454.01978.3B
  5. Greenhalgh DG, Saffle JR, Holmes JHt, Gamelli RL, Palmieri TL, Horton JW, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007;28:776-90. https://doi.org/10.1097/BCR.0b013e3181599bc9
  6. Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med 1982;11:260-2. https://doi.org/10.1016/S0196-0644(82)80096-6
  7. Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013;17:R115. https://doi.org/10.1186/cc12787
  8. Schuetz P, Birkhahn R, Sherwin R, Jones AE, Singer A, Kline JA, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study. Crit Care Med 2017;45:781-9. https://doi.org/10.1097/CCM.0000000000002321
  9. Cabral L, Afreixo V, Meireles R, Vaz M, Marques M, Tourais I, et al. Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study. BMC Anesthesiol 2018;18:122. https://doi.org/10.1186/s12871-018-0585-6
  10. Park T, Lim CM, Koh Y, Hong SB. Utility of serum procalcitonin for diagnosis of sepsis and evaluation of severity. Tuberculosis and Respiratory Diseases 2011;70.